[Effectiveness of the treatment plan for androgenetic alopecia].
The genetic background and some environmental factors have been reported as cause of hair growth disturbances. The damage of the biological rhythm of hair growth causes the decrease of length of phase and stunted hair growth, leading to diffuse alopecia. The scheme of hair loss treatment, by means of preparations affecting pathogenetical mechanisms of diffuse hair loss development is offered. The clinical evaluation of hair post treatment condition is given as well. The clinical study has shown high therapeutic efficacy of proposed scheme for treatment of patients, suffer from "acute, chronic diffuse hair loss", androgenetical alopecia. Authors conclude that proposed scheme allows obtaining marked results.
Tsiskarishvili
N V
NV
Tsiskarishvili
Ts I
TsI
D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000188:drug therapy* / Q000503:physiopathology; D000935:Antifungal Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D000935:Antifungal Agents; D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D018120:Finasteride; D008914:Minoxidil; D015032:Zinc; D007654:Ketoconazole